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The core gene (C-gene) promoter and regulatory sequences play a central role in the hepatitis B virus (HBV) life cycle. They are essential
for the synthesis of the pregenomic and precore mRNA. The pregenomic RNA is the template required for replication and also the template
for the synthesis of the core protein and polymerase. Here, we report the in vivo existence and functional characterization of HBV variants
that lack the C-gene promoter region and the regulatory sequences located therein.
HBV promoter fragments were isolated by PCR from sera of chronic carriers and characterized. Truncated promoter elements were
identified, and then tested in the context of wild-type genomes in the HuH-7 cell line. The expression of the recombinant HBV genome
resulted in the synthesis of surface proteins, and low level of core protein as well as a transcript pattern similar to, but smaller in size to wild-
type virus. The recombinant HBV genome with the truncated promoter region produced pregenomic RNA-like transcripts. These transcripts
were encapsidated and reverse transcribed when complemented by sufficient core and polymerase protein. These date provide an explanation
as to why such deletion mutants of HBV can be produced at all, they highlight the functional potentials of viral sequences activated by
mutations and may be of relevance for viral evolution and persistence.
D 2004 Elsevier Inc. All rights reserved.
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Hepadnaviruses are small, enveloped DNAviruses with a
narrow host range and a distinct organ tropism, which cause
acute and chronic liver infections of their respective hosts.
The human hepatitis B virus (HBV) afflicts approximately
300 million people worldwide and chronic infection with
HBV is associated with an increased risk for the develop-
ment of hepatocellular carcinoma (Ganem and Prince, 2004;
Seeger and Mason, 2000).0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: Hans.Netter@med.monash.edu.au (H.J. Netter).The viral genome is a partially duplex, relaxed circular
DNA molecule (rcDNA) with a size of about 3 kb, which
upon cell entry is converted into a covalently closed circular
episome (cccDNA). The cccDNA is then transcribed by the
host RNA polymerase II synthesizing subgenomic mRNAs
and greater-than-genome length RNA intermediates known
as pregenomic RNA/core-mRNA (pgRNA/C-mRNA) and
precore mRNA. Distinctive for all hepadnaviruses is the
way of replication by reverse transcription of the pgRNA
into rcDNA initiated by a protein-primed mechanism
(Weber et al., 1994; Zoulim and Seeger, 1994).
The organization of the viral genome is very compact
with four open reading frames (ORFs) and at least four
promoter and two enhancer elements are located within the
ORFs. These elements regulate the expression of the
envelope proteins (surface antigens, sAg), the nucleocapsid
protein/e-antigen, polymerase protein (Pol-protein), and the04) 437–446
Fig. 1. Serum samples derived from two HBV chronic carriers were used
to amplify HBV-specific sequences (A, B). A set of primers, P1 and P2,
were used to amplify PCR products specific for the X-gene and part of
the core-gene. A plasmid containing an HBV full-length genome was
used as a control template (C). The PCR products were separated on a
1% agarose gel.
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2000). Briefly, the synthesis of the sAgs is regulated by two
promoters. The preS1-promoter regulates the transcription
of a mRNA that is translated into the large form of the sAg
(sAg-L). From the S-promoter, transcripts with different 5V-
ends are synthesized, which are translated into the middle
and small form of the sAg (sAg-M and sAg-S, respectively).
The sequences of all three sAg-proteins are coterminally
identical but differ N-terminally due to translation initiation
at three different in-phase start AUG-codons. Hence, the
sAg-S is composed of just the S-domain with 226 amino
acids, the sAg-M protein has an additional N-terminal preS2
extension (55 amino acids), and the sAg-L contains both the
additional preS2 extension and the preS1 domain with 163
amino acids. A third promoter has been identified upstream
of the X-ORF, which gives rise to transcripts essential for
the synthesis of the X-protein (Treinin and Laub, 1987). In
addition, short transcripts of the X-gene have been mapped
which are derived from an X-intragenic promoter (Zheng et
al., 1994). Overlapping with the X-promoter and part of the
X-ORF is a post-transcriptional regulatory element (PRE)
essential for the transport of HBV transcripts (Donello et al.,
1996; Huang and Liang, 1993; Huang and Yen, 1994; Zang
and Yen, 1999). The fourth major promoter, the core
promoter, is localized within the X/precore region and
contains several cis- and trans-acting elements that are
required for virus replication (Kramvis and Kew, 1999). The
core promoter is essential for the production of the 3.5-kb
pg- and precore transcripts. Both transcripts are initiated just
30 nucleotides apart from each other but they have quite
different functions in the life cycle of HBV. The precore
transcript is the template for the synthesis of the precore
protein, which is processed and results in the secretion of the
processing product, designated e-antigen (eAg). The pg-
transcript is encapsidated with the help of the Pol-protein
into capsids and reverse-transcribed into rcDNA. The
second function of the pg-transcript is its mRNA template
function for synthesis of the core- and Pol-proteins. Taken
together, the core promoter that directs the synthesis of the
pg-transcript/C-mRNA is of paramount importance for the
HBV life cycle.
The core promoter has been characterized in detail and
a basal core promoter with four TA-rich sequences has
been defined. A stretch of 15 nucleotides that contains
one TA-rich sequence has been shown to be sufficient to
direct the precise initiation of the precore- and the pg-
transcript/C-mRNA (Chen et al., 1995; Yuh et al., 1992).
In contrast, Yu and Mertz (1996) showed that the
promoters for the synthesis of the pre-C and pregenomic
mRNAs are genetically distinct and differentially regu-
lated. Moreover, this regulatory region is very complex
with the enhancer 2 (EnII) element overlapping with the
core promoter upstream sequence (Yuh and Ting, 1990).
EnII is an essential cis-element for the transcriptional
regulation of HBV gene expression and exhibits hepato-
cyte specificity (Guo et al., 1993; Ishida et al., 2000;Johnson et al., 1995; Li et al., 1995, 1998; Lo´pez-Cab-
rera et al., 1991; Wang et al., 1998).
Due to the compact organization, all HBV RNAs
terminate at the identical poly(A) signal, and the poly-
adenylation efficiency depends on activator elements
located upstream to the poly(A) signal (Cherrington et al.,
1992; Russnak, 1991; Russnak and Ganem, 1990).
The identification of HBV mutants has contributed to the
understanding of different aspects in regard to the molecular
biology of HBV and HBV-related pathogenesis during a
natural infection (Gu¨nther et al., 1995, 1999). HBV mutants
within the X/precore region have been described. These
variants with mutations showed deletions of regulatory
elements and it was not known whether such mutants were
capable of independent replication or whether they were
generated during infection and packaged (Feitelson et al.,
1994, 1995a, 1995b, 1995c; Laskus et al., 1994). On the
molecular level, it is unknown how these mutants synthesize
pg-transcripts without the presence of the precore/core
promoter elements. We have identified HBV-genomes with
deletions in this essential region and recognized aspects of
their alternative replication pattern.Results
Identification of novel HBV variants
In order to search for core promoter mutants, one set of
primers, P1 and P2, was used to amplify HBV-fragments
derived from the HBV-nick region including the X-region
and the core promoter/enhancer II (EnII). Primer P1 anneals
to a sequence upstream from the X-ORF, primer P2 binds to
Fig. 2. Genomic organization of wild-type and mutant genomes. The top panel shows the organization of a wild-type HBV genome. Regulatory elements (TA4,
DR1, DR2), the start sites for the preC mRNA and pregenomic RNA, and the open reading frames for the polymerase gene, precore/core gene, and the X gene
are indicated. The deleted sequences in mutant 2 (middle panel) and mutant 17 (bottom panel) are indicated with dashed lines. Nucleotides 1592 to 1825 and
nucleotides 1637 to 1819 are deleted in M2- and M17-genomes, respectively.
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from chronic HBV carriers used to amplify HBV-specific
sequences did not result in a discrete band of the expected
length but in a smear indicative for a heterogeneous
population of HBV-molecules (Fig. 1, lanes A and B).
Direct sequencing did not reveal a nucleotide consensus
sequence probably due to the heterogeneity of the sequenceFig. 3. Northern blot analysis to determine the transcripts synthesized by
M2- and M17-genomes. HuH-7 cells were transfected with plasmids
expressing wild-type HBV (WT), M2- and M17 HBV (M2 and M17), and
mock. Poly(A) RNAs were isolated, loaded onto a formamide gel,
separated and transferred to a nitrocellulose membrane. The marker (M)
was a 3.2-kb HBV-RNA transcript.(data not shown). PCR fragments derived from one chronic
HBV carrier (patient B, see the corresponding amplified
DNA in Fig. 1, lane B) were cloned into the pBluescript
SK() vector to determine the sequences of individual
PCR-molecules. In total, 30 clones were sequenced with
five sequences showing insertions and deletions in the
amplified region (data not shown). Surprisingly, three of the
five cloned HBV-specific fragments correspond to genomes
with deletions in the nick region. The sequences of two of
these fragments revealed large deletions beginning at theFig. 4. Analysis of 5V-RACE amplification products by 2% agarose-gel
electrophoresis. The amplification products were derived from total RNA
harvested from HuH-7 cells after transfection with plasmids expressing
wild-type HBV (Wt) and mutant HBV (pM2 and pM17). Marker (M):
100-bp ladder marker.
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shown in Fig. 2). The corresponding genomes would not be
able to express X-protein, would lack most or all of the
cohesive overlap regions between plus and minus strand,
and also regulatory elements within the core promoter
required for pregenomic synthesis and replication. In detail,
both mutants (M2 and M17) show deletions in the area of
the core-promoter/EnII (M2: 233 nucleotides, M17: 182
nucleotides), which extend far into the X-gene (Fig. 2).
Essential regulatory elements are missing, for instance, the
TA4 element of the basal core promoter, which is required
for initiation of the precore-RNA and the pregenomic RNA
(Chen et al., 1995). Also, part of the posttranscriptional
regulatory element (PRE) involved in cytoplasmic transport
of the RNAs (Huang and Liang, 1993; Zang and Yen, 1999)
is deleted. In addition, both mutants do not contain the start-
ATG for the precore protein and therefore should be unable
to produce precore protein and its processing product e-
antigen. Mutant M17 has a complete polymerase open
reading frame, in contrast M2 has seven amino acids at the
very C-terminus of the Pol-protein deleted, but is fused
instead to 31 amino acids not related to the HBV-polymer-
ase sequence. The latter may be associated with a defect in
polymerase function. The C-terminal domain of the X-
protein of M2 and M17 has an internal deletion of 78 and 61
amino acids, respectively, which may interfere with the X-
function as a transcriptional regulatory protein. Mutant M17
contains the DR2 element whereas M2 does not (Fig. 2).
Hence, the M2 genome should not be able to synthesize
DNA plus strands, if no alternative sequence for DR2 is
used.Fig. 5. Nucleotide positions of the 5V-end of the RACE products. The top panel sho
the location of the start-ATGs for the precore and core proteins (Yaginuma et al., 19
M2 and M17), and the location of the 5V-position is indicated as well as the numMutants synthesize pregenomic-like transcripts
Major truncations within the regulatory region interfere
with the synthesis of the pregenomic RNA that acts as the
template for DNA synthesis. Hence, replication should not
be possible, and such viral DNA genomes should not exist
in the serum according to current knowledge on the function
of these sequences. In order to decipher whether such
unconventional genomes may synthesize pregenomic-like
RNA transcripts by activating promoters that are inactive or
hardly active in wt-genomes, two amplified HBV fragments
(representing M2 and M17) were tested in the context of a
wild-type genome (Galibert et al., 1979). The corresponding
wild-type region was substituted with the mutated sequence,
and the resulting dimeric HBV constructs pMcH2-2 (pM2)
and pMcH2-17 (pM17) expressed the mutant M2- and M17-
genomes, respectively. The plasmids pM2, pM17, and the
wild-type construct (pWT) were transfected into the
hepatoma cell line HuH-7; the cells and the cell culture
medium were harvested 5 days after transfection.
Poly(A) RNA was isolated from the transfected cells
and equal amounts were analyzed by Northern blotting to
unravel which kind of transcripts can be synthesized by
the mutated M2- and M17-genomes. For the wild-type
construct, a 3.5-kb transcript was identified that repre-
sents the pgRNA and the preC-mRNA. In addition,
smaller transcripts (about 2.1/2.4 kb) were observed,
which represent mRNAs encoding the envelope proteins
(Fig. 3, lane WT). Surprisingly, for both M2- and M17-
mutants, which do not contain a pregenomic promoter,
transcripts were also identified similar in size as the wild-ws the characterized 5V-ends for the preC-mRNA and pregenomic RNA and
87). The results of the 5V-RACE are shown in the framed panels (wild-type,
ber of the corresponding sequenced clones.
Fig. 6. Detection of surface antigen, sAg (HBs) (top panel), and e-antigen
(HBe) (bottom panel) from the supernatant of HuH-7 cells transfected with
pWT, pM2, and pM17. The outcome of two independently performed
transfection assays are shown (transfection 1 and transfection 2).
Fig. 7. Detection of core- and Pol-proteins by immunoblotting. Cells were
transfected with plasmids CH3142, pM2, pM17, pWT, and as indicated by
a combination of different plasmids. The cells were lysed in PAGE-loading
buffer, separated, and analyzed. (A) Detection of the core protein. (B)
Detection of the Pol-protein.
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bpregenomic-like RNA moleculesQ from both mutants was
less (4-fold less for M2 and 8-fold less for M17) than
pgRNA derived from wild type (Fig. 3). These results
demonstrate that both mutants lacking the C promoter
can synthesize bpregenomic-like RNA moleculesQ. The
shorter transcripts specific for the envelope proteins
(preS- and S-mRNAs) could be separated by gel electro-
phoresis (Fig. 3). As expected, the mutant preS- and S-
mRNAs are smaller in size than the corresponding wild-
type mRNAs. Because all the transcripts are terminated at
the identical poly(A) site, these mRNAs transcripts
contain a shorter 3V untranslated region due to the
deletion and are therefore shorter than the wild-type
transcripts (Fig. 3). The amount of the envelope mRNAs
from both mutants was less (6-fold less for M2 and 10-
fold less for M17) compared to the wild-type S-mRNA
(Fig. 3).5V-RACE experiments were applied to identify the cDNA
ends of the mRNA transcripts. HuH-7 cells were transfected
with the plasmids pWT, pM2, and pM17, total RNA isolated
and 5V-RACE experiments performed. The HBV-specific
RACE primer used anneals to a sequence downstream to the
polyadenylation site of the HBV transcripts and therefore
should result only in amplification products derived from
pregenomic-like RNAs (or pregenomic RNA for WT) but
not from subgenomic envelope- or X-specific mRNAs.
RNA preparations derived from pWT-transfected cells
resulted in two major RACE products (Fig. 4) representing
the start sites for the preC-RNA and pregenomic RNA as
verified by cloning of the RACE products and sequencing
(Fig. 5). The 5V-ends of the transcripts derived from the
wild-type HBV construct were predominantly mapped at
nucleotide position 1787 and position 1821 (Fig. 5), which
correspond to known preC-RNA and pgRNA start sites,
respectively (Yu and Mertz, 1996; Yaginuma et al., 1987).
Amplification of the 5V-RACE-products for the pM2 and
pM17 mutants did not result in discrete major amplification
products but in a heterogenous population of molecules in
the same size range as the amplification products obtained
with the wt HBV-DNA (Fig. 4). Sequencing of cloned
molecules thereof indicated various transcription start sites
upstream and downstream of the start-ATG of the core gene.
The longest RACE products derived from M2-specific
transcripts were located at nucleotide positions 1842 and
Fig. 8. Demonstration of the presence of replicative forms of HBV DNAs
by Southern blot analysis. HuH-7 cells were separately transfected with
wild-type HBV (Wt), pM2 (M2), and pM17 (M17) or cotransfected with
plasmids pM2 and CH3142, pM17 and CH3142. Mock represents a sample
derived from untransfected HuH-7 cells. Replicative HBV DNA inter-
mediates were isolated, separated on an agarose gel, transferred onto a
membrane, and visualized with a full-length HBV probe. For the visual-
ization of the WT-sample and the M2- and M17-samples, the filter was
exposed for 2 h and for 2 days, respectively.
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positions 1850 and 1863/4 (9/23 clones sequenced); the
shortest mapped 5V-ends are located at positions 1958 to
1961 (Fig. 5). These data suggest that the pregenomic-like
RNAs synthesized by M2 and M17 may be driven from the
intragenic X-promoter (Zheng et al., 1994) giving rise to
transcripts with heterogenous 5V-ends.
Identification of M2- and M17-specific gene products
In order to investigate which HBV-specific proteins
can be synthesized by the mutated genomes, the cell
culture supernatant was monitored for the presence of
sAg and eAg, the corresponding cell pellet was
harvested and examined for the presence of core- and
Pol-proteins.
Both mutants (M2 and M17) synthesize sAg-tran-
scripts (Fig. 3), and sAg was detected in the cell culture
supernatant, though significantly less than from wild-type
genome transfected cells (Fig. 6, upper panel). This is
probably due to the lower copy number of transcripts
synthesized by the mutant genomes.
The pregenomic-like RNA synthesized by genomes
with deletions in the core promoter region of HBV are
different at their 5V-terminal ends compared to the wild-
type pregenomic RNA, and therefore may not act as
template for protein synthesis. As expected and different
from the wild-type genome, cell culture supernatant
derived from HuH-7 cells transfected with pM2 or pM17
did not contain a detectable level of eAg (Fig. 6, lower
panel) due to the lack of the translation start codon of the
precore ORF. For analysis of intracellular expression of
the core- and Pol-protein, the cell pellet was resuspended
in PAGE loading buffer, and examined by Western
blotting. Core protein was detected in cells transfected
with pM2 and pM17. However, compared to cells
transfected with pWT, at least an order of magnitude
less core protein was expressed by the pregenomic-like
RNAs of the mutant genomes (Fig. 7A, lanes M2, M17,
and WT).
Similarly, the Pol-proteins synthesized by the mutant
pregenomic-like RNAs were very poorly expressed and
hardly visible compared to the strong signals obtained
for Pol-protein expressed by pWT (Fig. 7B, lanes M2,
M17, and WT). Taken together, these data indicate a
very poor translation efficiency of the pregenomic-like
RNAs.
Replication competence of M2- and M17-genomes
In order to investigate whether the pregenomic-like
RNAs of both mutants M2 and M17 are competent for
encapsidation and reverse transcription into rcDNA,
intracellular core particles were isolated, and DNA
replication was analyzed by Southern blotting. HuH-7
cells were transfected separately with pM2, pM17, andpWT. In addition, the M2- and M17-genomes were
cotransfected with the plasmid CH3142 for complemen-
tation with sufficient amounts of core- and Pol-protein in
trans. These proteins were detected by immunoblot
analysis (Figs. 7A, B). The plasmid CH3142 (Bartenschl-
ager and Schaller, 1992) contains a replication-incompetent
HBV genome due to mutations within the encapsidation
site. It synthesizes all the viral proteins but substantially less
core protein than the wild-type genome (Fig. 7A, lanes
pCH3142, WT). For unknown reasons, more core protein
was expressed after pCH3142/pM2 and pCH3142/pM17 co-
transfections. Possibly, the mutant genomes affect by
unknown mechanisms transcription activity of the core
promoter or the stability of the transcripts or core protein.
Transfection with only pM2 and pM17 failed to produce
detectable levels of replication intermediates (Fig. 8, lanes
M2 and M17) indicating that both mutants replicate either at
undetectable low levels, or are completely replication
incompetent. However, after co-transfection of pM2 with
pCH3142, replication intermediates were detected indicat-
ing successful trans complementation and competence of the
pregenomic-like RNAs for encapsidation and reverse tran-
scription into DNA (Fig. 8). Therefore, the presence of core-
and Pol-proteins enhances the replication efficiency of M2-
and M17-genomes.
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In this report, we have identified and characterized
truncated HBV genomes with most of the core promoter
region deleted. Because of the very compact organization
of the HBV genome, other important regulatory elements
are also effected, e.g., the activator sequences required
for polyadenylation (Cherrington et al., 1992; Russnak,
1991; Russnak and Ganem, 1990), and part of the
posttranscriptional regulatory element (PRE) (Donello et
al., 1996; Huang and Liang, 1993; Huang and Yen, 1994;
Huang et al., 1996; Zang and Yen, 1999). The detection
of HBV DNA in the serum without a complete precore
region indicates that bpregenomic-likeQ molecules must
exist that are packaged, reverse transcribed, and the
corresponding cDNA secreted in viral particle encapsi-
dated form.
Functional analysis of the mutant regions in the
context of a well-characterized wild-type HBV reference
genome revealed that the corresponding viruses synthe-
size bpregenomic-likeQ RNAs as well as sAg-mRNAs.
The bpregenomic-likeQ RNA molecule is similar in size to
the pregenomic RNA derived from wild-type HBV
genome. The size suggests that the internal-X promoter
may be responsible for the synthesis of the bpregenomic-
likeQ RNAs (Zheng et al., 1994). HBV-specific primers
that anneal to transcripts closer to these potential start
sites or closer to the HBV-X promoter did not result in a
clear outcome due to the annealing of these primers to
sAg-specific transcripts (data not shown). Reporter gene
assays are required for a further detailed analysis of the
cryptic promoter elements.
The mutant genomes express a substantially lower
amount of core protein, and probably minute amounts of
Pol-protein, compared to the wild-type genome. There-
fore, efficient replication and packaging of the
bpregenomic-likeQ RNA depends on the presence of
wild-type genomes that provide core- and Pol-proteins
in trans. The M2- and M17-dependent synthesis of the
core- and Pol-proteins is probably compromised by the
presence of the lower amount of bpregenomic-likeQ
RNAs, by the deletion of PREh sequences (Donello et
al., 1996; Huang et al., 1996), and by the deletion of
sequences contributing to the efficiency of polyadenyla-
tion (Cherrington et al., 1992; Russnak, 1991; Russnak
and Ganem, 1990). Also, the 5V-untranslated region of the
bpregenomic-likeQ RNAs that differs from the pgRNA-
specific 5V-untranslated region may interfere with efficient
use as template for core- and Pol-translation.
The sAg-specific mRNA transcripts have a faster
migration pattern than the wild-type sAg transcripts due
to the truncation at the 3V-end. The lower level of
envelope-specific mRNAs expressed by the M2- and
M17-genomes can be explained by the deletion of PREh-
specific sequences leading to less transport of the
corresponding RNAs to the cytoplasm and increaseddegradation in the nucleus (Donello et al., 1996; Huang
et al., 1996). In addition, deletion of enhancer sequences
may down-regulate the synthesis of the sAg-specific
RNAs (Li and Ou, 2001; Yee, 1989), and missing
polyadenylation activator sequences may contribute to
an inefficient polyadenylation and lower stability of S-
mRNA. The polyadenylation signal of orthohepadnavi-
ruses is UAUAAA rather than the optimal AAUAAA
sequence, and hence, this signal sequence acts ineffi-
ciently (Russnak and Ganem, 1990). For ground squirrel
hepatitis B virus (GSHV) (Cherrington et al., 1992;
Russnak, 1991; Russnak and Ganem, 1990), positive
regulatory elements for polyadenylation were described.
Multiple activator elements that are required for efficient
GSHV RNA processing were identified within the
upstream 400 nt region 5V to the hexanucleotide. The
HBV genomes M2 and M17 have regions deleted (93
to 326, or 99 to 281, respectively) that correspond
to the GSHV regions that contain part of the poly-
adenylation activator sequences. However, both HBV
mutants have retained sequences upstream to the poly(A)
signal that may also contain potential activator sequences
for polyadenylation. GSHV contains an element (PS2) at
nucleotide positions 43 to 96 that contributes to
polyadenylation (Cherrington et al., 1992). Because of the
loss of several activator elements, the bpregenomic-likeQ
RNA synthesized by M2 and M17 are expected to be
polyadenylated with lower efficiency than wild-type
pgRNA. The diminished polyadenylation efficiency may
be essential for the synthesis of the bpregenomic-likeQ
RNAs due to the bypass of the 5V-poly(A) signal. An
alternative polyadenylation site described by Hilger et al.
(1991) is deleted in both the truncated M2 and M17
sequences.
Deletion of the DR2 element in mutant M2 does not
allow the translocation of the RNA primer to the
homologous DR2 site on the DNA minus strand. For
wild-type HBV, this translocation step is essential for
formation of the relaxed circular form of the HBV
genome. Without translocation of the RNA primer, which
also occurs in wild-type HBV at low frequency, double-
stranded linear HBV DNA molecules are formed by in situ
priming of DNA plus-strand synthesis (Staprans et al.,
1991). Whether the mutant genomes upon complementa-
tion by other HBV genomes can form only such linear
DNA molecules or have invented a nonconventional novel
mechanisms for relaxed circle DNA synthesis remains to
be studied. Taken together, the truncated genomes are not
competent for an efficient autonomous replication. They
can be complemented in trans with core- and Pol-protein,
and consequently the bpregenomic-likeQ RNAs, which
contain the epsilon-signal can be rescued, and replication
can occur. This study provides a first explanation as to
why core promoter deletions variants can exist in vivo and
be secreted in virion-encapsidated form. Our study also
indicates that HBV up-regulates weak promoter activities
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synthesis of its most important viral transcript, the
pregenomic RNA as a rescue pathway when essential
sequences are deleted during the course of chronic
infection. The presence of deletion mutants of HBV and
their interplay with wild-type genomes may contribute to
the progress and the persistence of the disease. It has been
proposed particularly for quasispecies-like infectious
agents such as hepatitis C virus that a great proportion
of virions in the serum contain defective genomes that
may decrease the cytopathic potential of this virus and
facilitate persistence (Esteban et al., 1999). Furthermore,
replication competent defective genomes may interfere
with the overall expression of wild-type genomes due to
competition and this may compromise an anti-HBV
cellular immune response, and therefore may contribute
to persistence.Materials and methods
Patients’ sera
Two patients had a history of an acute hepatitis in
1976. Serological tests were performed in May 1991, sera
analyzed were sAg- and anti-eAg-positive. Chronic
lobular hepatitis was diagnosed based on the examination
of a liver biopsies. The sera were negative for markers of
hepatitis C virus (HCV).
Isolation of viral DNA from serum
To 0.5 ml of the serum, 0.1 ml digestion buffer (3%
SDS, 60 mM EDTA, 60 mM Tris–HCl, pH 7.5, 1.2 mg/
ml Proteinase K) was added. This mixture was incubated
for at least 7 h at 37 8C, then the DNA was extracted
twice with phenol and subsequently with chloroform. The
DNA was precipitated with isopropanol in the presence of
tRNA. The pellet was washed with 70% ethanol and then
dissolved in 100 Al H2O.
Amplification of the HBV-specific fragments
HBV DNA isolated from the serum was amplified by
PCR in 100 Al reaction buffer (0.2 mM dNTPs, 1.5 mM
MgCl2, 10 mM Tris–HCl pH 8.3, 50 mM KCl, 0.1–0.01
ng DNA template, 10% glycerol), 2.5 U Taq polymerase
(Roche, Germany), 50 pmol of primer P1 and P2. Primer P
1 binds to the region upstream from the X-open reading
frame at position 1188 to 1207 (5V-GCTGACG-
CAACCCCCACTGG-3V), primer P2 anneals within the
core-open reading frame between position 2102 and 2084
(5V-GTCATTAGTTCCCCCCAGC-3V). The nomenclature
is according to Galibert et al. (1979). The amplification
was performed for 35 cycles at 94 8C for 30 s, 55 8C for
30 s, and 72 8C for 1 min.Cloning of the PCR products and the construction of
plasmids containing the PCR fragment within the context of
a reference HBV genome
The PCR products were blunt-ended by a Klenow-fill-in
reaction and purified. The fragments were then ligated into
the pBluescript SK() vector (Stratagene, USA), which was
linearized with EcoRV. Two plasmids were identified with
deletions in the HBV X-gene and precore/core-promoter
region (#2 and #17). These fragments were released from the
pBluescript SK() vector by NcoI and BglII digestion and
introduced into the wild-type HBV genome of the pMcH
construct by replacing the corresponding wild-type region.
The plasmid pMcH (derivative of pMac5-8, Stanssens et al.,
1989) contains one full-length genome of the HBV subtype
ayw (Galibert et al., 1979). The derivatives pMcH2 and
pMcH17 that contain the mutated fragment in the complete
HBV genome were used to create the dimer constructs. Both
pMcH2 and pMcH17 were partially digested and in parallel
completely digested by EcoRI. The released monomeric
HBV2- and HBV17-genomes were ligated to the corre-
sponding linearized plasmid pMcH2 or pMcH17. Plasmids
were obtained that contain the modified HBV genomes in
dimeric form, pMcH2-2 (pM2) and pMcH2-17 (pM17).
Transfection of HBV DNA
For DNA transfection, a calcium phosphate precipitation
method was used as described (Graham and van der Eb,
1973). HuH-7 cells (Nakabayashi et al., 1982) were grown
on 60  15 mm tissue culture dishes (Falcon, Becton
Dickinson, U.K.) to approximately 80% confluence. The
medium was changed 1 day after transfection, and the cells
were harvested 4 days later. HBV sAg and eAg were
assayed by using commercially available kits (Abbott,
USA). The CMV-SEAP plasmid was cotransfected and
SEAP activity was measured from cell medium as control
for transfection efficiency (Berger et al., 1988).
Purification and detection of HBV DNA from intracellular
core particles
Cells were washed two times with ice-cold PBS, then
incubated for 15 min in 1 ml lysis buffer (50 mM Tris pH
7.4, 1 mM EDTA, 1% Nonidet P-40) per dish. The lysed
cells were transferred to Eppendorf tubes, vortexed, and
allowed to stand on ice for 15 min. The nuclei were
removed by centrifugation for 1 min in a microfuge, then
500 Al supernatant was adjusted to 20 mM MgCl2 and
digested with DNaseI (final concentration 200 Ag/ml) for 30
min at 37 8C. The reaction was stopped by adding EDTA
(final concentration 50 mM). Then, the proteins were
digested by proteinase K (final concentration 1 mg/ml) for
3 h at 37 8C in the presence of 1.5% SDS. The nucleic acids
were extracted with phenol/chloroform and precipitated
with isopropanol and 40 Ag tRNA per milliliter. The pellet
S.-F. Chang et al. / Virology 330 (2004) 437–446 445was washed one time with 70% ethanol. The DNA was
analyzed by Southern blotting.
Northern blot analysis
The poly(A) RNA was isolated from transfected HuH-7
cells, separated on an 1% agarose gel containing formamide,
then blotted onto a Hybond membrane (Amersham). The
membrane was hybridized with 32P-labeled full-length HBV
DNA. The presence of HBV-specific RNA was visualized
by exposing the membrane using the Phosphoimager system
(Fuji Base, 2000).
Immunoblotting analysis
SDS loading buffer was added to the transfected cell
lysates, the proteins were separated by SDS-polyacrylamide
gel electrophoresis and transferred to a nitrocellulose
membrane or PVDF membrane. The membranes were
incubated with a rabbit antiserum specific for HBV core-
protein or a mouse monoclonal antibody specific for HBV
Pol-protein. The proteins were then visualized by using a
peroxidase-coupled anti-rabbit IgG antibody (Dako Corp.)
or anti-mouse IgG (Dako Corp.) in the presence of a
chemiluminescence substrate (ECL Kit, Amersham).
5V-RACE analysis
The cDNA was synthesized and amplified by using the
5V-RACE amplification kit according to the manufacturer’s
instructions (Clontech). The HBV-specific RACE primer
(5V-GGCTTCCCGATACAGAGCTGAGGCG-3V) is located
downstream of the poly(A) signal and complementary to
nucleotide positions 2001–2025. The PCR products were
cloned by using pGEMR-T Easy system (Promega) and
analyzed by sequencing.Acknowledgments
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